×
Imris Receivables 2010-2014 | IMRSQ
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Imris receivables from 2010 to 2014. Receivables can be defined as the total amount of collectibles for a company
View More
Imris Receivables 2010-2014 | IMRSQ
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Imris receivables from 2010 to 2014. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Intuitive Surgical (ISRG)
$183.7B
Thermo Fisher Scientific (TMO)
$157.2B
Edwards Lifesciences (EW)
$44.7B
Alcon (ALC)
$42.9B
IDEXX Laboratories (IDXX)
$41.9B
DexCom (DXCM)
$33B
IQVIA Holdings (IQV)
$27.4B
Mettler-Toledo (MTD)
$24.6B
STERIS (STE)
$22.4B
SONOVA HOLDING (SONVY)
$17.3B
Waters (WAT)
$17.2B
Hologic (HOLX)
$14.2B
Sysmex ADR (SSMXY)
$10.5B
Penumbra (PEN)
$9.1B
Masimo (MASI)
$8.6B
Globus Medical (GMED)
$7.7B
Glaukos (GKOS)
$5.6B
Teleflex (TFX)
$5B
Integer Holdings (ITGR)
$4.1B
TransMedics (TMDX)
$3.8B
PROCEPT BioRobotics (PRCT)
$3.2B
LivaNova (LIVN)
$2.3B
Nihon Kohden (NHNKY)
$2.2B
Veracyte (VCYT)
$2B
Elekta AB (EKTAY)
$1.9B
Alphatec Holdings (ATEC)
$1.6B
Artivion (AORT)
$1.3B
Paragon 28 (FNA)
$1.1B
OPKO Health (OPK)
$1.1B
Pulse Biosciences (PLSE)
$1.1B